AzTrials
AzTrials

EpilepsyNCT07224191

Hippocampal Oscillations During Exploration

A study testing Visual Exploration and Ambulatory Exploration in people with Epilepsy, run by NYU Langone Health at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulatory exploration in… Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Epilepsy
What is being tested?
Visual Exploration and Ambulatory Exploration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteUnited States
Study dates
25 Feb 2026to 8 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All subjects:
  • Adults (18-70 years)
  • Able to provide informed consent
  • Aim 1: Surgical epilepsy patients' inclusion criteria
  • Implanted hippocampal depth electrodes for Stage 1 epilepsy surgery
  • MMSE>=24
Show all 13Show fewer
  • Aim 2: RNS patients Inclusion criteria
  • Implanted RNS device with at least one hippocampal depth electrode
  • At least 5 months post-implantation to avoid the post-implant effect
  • Have a relatively low number of seizures, defined as <1 generalized tonic-clonic or other seizure with potential to fall or cause injury per month
  • Able to walk and wear research equipment without assistance
  • MMSE>=24
  • Aim 2: Healthy Control Inclusion criteria • Able to walk and wear research equipment without assistance

Who cannot join

  • RNS patients, Aim 2:
  • Any generalized tonic-clonic seizure within the last week
  • All subjects:
  • Legally blind
  • Smoking tobacco, marijuana, recreational drugs or alcohol use within 1 week of cognitive testing
  • Unable to give informed consent
  • Pregnancy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • NYU Langone Health

    New York, New York, 10016

    Recruiting

Other trials in United States

About this study

Official title: Human Hippocampal Oscillations During Visuomotor Exploration

The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulatory exploration in patients implanted with RNS devices.

Read the detailed description

Aim 1 - Visual Exploration in Surgical Patients Investigators will study 20 surgical patients with high-resolution intracranial EEG (iEEG) to investigate hippocampal activity during visual exploration. Participants will view between 10-15 panoramic environments using Meta Quest AR/VR glasses while their eye movements and head turns are tracked. Eye-tracking, head-turn, and iEEG data will be synchronized with visual stimuli, and intracranial EEG and single-unit data will be analyzed for changes in neuronal firing and brain activity before and after saccades.

Aim 2 - Ambulatory Exploration in RNS Patients and Healthy Controls Investigators will study 12 epilepsy patients with implanted responsive neurostimulator (RNS) devices and 24 healthy controls (HCs) during real-world exploration. Participants will walk through and explore visually distinct rooms while wearing synchronized high-density EEG (hdEEG), eye-tracking glasses, and body position sensors. Data from hippocampal iEEG, hdEEG, eye tracking, and motion sensors will be synchronized offline to examine brain-behavior relationships and the influence of cognitive load on saccade-hippocampal interactions.

Conditions
Epilepsy
Being tested
Visual Exploration, Ambulatory Exploration
Medical subject headings
Epilepsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Visual ExplorationOther

    Cognitive testing while admitted to the epilepsy monitoring unit (number of sessions will vary depending on patient availability and stamina).

  • Ambulatory ExplorationOther

    Series of cognitive tasks completed during a study visit.

Study groups in NCT07224191
Study groupRoleWhat they receive
Epilepsy Surgery PatientsExperimentalAim 1: Participants will be presented with between 10-15 unique immersive virtual environments (depending on patient tolerance) for patients to explore using VR glasses. Control tasks will be run to account for eye movements during non-navigation. For recording eye movements in darkness during REM sleep, as part of a control task, 4 electrodes will be placed above and below both eyes, a standard technique in polysomnographic studies.
Receives: Other: Visual Exploration
Patients with RNS DevicesExperimentalAim 2: Participants will walk between 4-6 rooms within an office floor. Each office will contain generic objects (office furniture, computers, lighting) and unique objects (artwork, photographs, books, and personal items). As control conditions, subjects will first be asked to walk around and between two empty rooms under different lighting conditions and speeds. Participants will also be asked to participate in all awake saccade control conditions (without a visual cognitive load).
Receives: Other: Ambulatory Exploration
Healthy Control ParticipantsExperimentalAim 2: Participants will walk between 4-6 rooms within an office floor. Each office will contain generic objects (office furniture, computers, lighting) and unique objects (artwork, photographs, books, and personal items). As control conditions, subjects will first be asked to walk around and between two empty rooms under different lighting conditions and speeds. Participants will also be asked to participate in all awake saccade control conditions (without a visual cognitive load).
Receives: Other: Ambulatory Exploration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hippocampal Theta Power Under High Cognitive Loads

    Aims 1 and 2. High cognitive loads defined as visual exploration of a complex scene with goal-driven task.

    Measured: Study Visit (Day 1)

  2. Hippocampal Theta Power Under Medium Cognitive Loads

    Aims 1 and 2. Medium cognitive loads defined as visual exploration of a simpler scene with fewer objects.

    Measured: Study Visit (Day 1)

  3. Hippocampal Theta Power Under Low Cognitive Loads

    Aims 1 and 2. Low cognitive loads defined as visual exploration of moving dots.

    Measured: Study Visit (Day 1)

  4. Hippocampal Theta Power Under No Cognitive Loads

    Aims 1 and 2. Low cognitive loads defined as staring at a blank field of view or REM sleep.

    Measured: Study Visit (Day 1)

  5. Coherence Time-Locked to the Saccade Under High Cognitive Loads

    Aims 1 and 2. High cognitive loads defined as visual exploration of a complex scene with goal-driven task.

    Measured: Study Visit (Day 1)

  6. Coherence Time-Locked to the Saccade Under Medium Cognitive Loads

    Aims 1 and 2. Medium cognitive loads defined as visual exploration of a simpler scene with fewer objects.

    Measured: Study Visit (Day 1)

  7. Coherence Time-Locked to the Saccade Under Low Cognitive Loads

    Aims 1 and 2. Low cognitive loads defined as staring at a blank field of view or REM sleep.

    Measured: Study Visit (Day 1)

  8. Coherence Time-Locked to the Saccade Under No Cognitive Loads

    Aims 1 and 2. Low cognitive loads defined as staring at a blank field of view or REM sleep.

    Measured: Study Visit (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2025
  2. Study start25 Feb 2026
  3. Primary completion8 Oct 2028 (estimated)
  4. Study completion8 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07224191
Sponsor's protocol ID
25-01119
Other IDs
R61DC022830-01
Status last verified
Jul 2026
First submitted
31 Oct 2025
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study will upload data into openneuro.org or comparable neuroscience data sharing platform, with data uploaded on a basis as specified by the conditions of awards supporting this research.

Questions about this trial

What is this clinical trial studying?

A study testing Visual Exploration and Ambulatory Exploration in people with Epilepsy, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anli Liu, MD, MA ((929) 455-2323, Anli.Liu@nyulangone.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hippocampal Theta Power Under High Cognitive Loads (time frame: Study Visit (Day 1)). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in